Loading…
Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007
Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobia...
Saved in:
Published in: | Annals of Saudi medicine 2010-09, Vol.30 (5), p.358-363 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223 |
---|---|
cites | cdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223 |
container_end_page | 363 |
container_issue | 5 |
container_start_page | 358 |
container_title | Annals of Saudi medicine |
container_volume | 30 |
creator | Al-Talib, Hassanain I Yean, Chan Y Al-Jashamy, Karim Hasan, Habsah |
description | Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility.
This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years.
The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P>.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin.
The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM. |
doi_str_mv | 10.4103/0256-4947.67077 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_be228b5ec5e346bb87720866da425465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A235994172</galeid><doaj_id>oai_doaj_org_article_be228b5ec5e346bb87720866da425465</doaj_id><sourcerecordid>A235994172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIlsKZG4rg0FO2_nZyQaoqSiu14lB6thx7sutV1l5sp9Je-O043bZiEbLksWbevPnwq6qPGC0YRvQMES4a1jG5EBJJ-ao6Rp3kDWNCvC7v5-hR9S6lNUIEMUrfVkcEiU5iiY-r37eQV864cXS-iZBcytrn-i7r7Wo3BhOMmVKtpwjF-JCKZ-P0WDs_gMku-DpH8DYVR30V0tblErz37gFictnVd9r5VN_qUe-S07WdovPLmpRWmnLJ99WbQY8JPjzZk-r-8tvPi6vm5sf364vzm8ZwjHNDh6HDjBHLewAOgvddSzEMFDi30pDOSiltZxllZTSpQUtOREtbgwaOCKEn1fWe1wa9VtvoNjruVNBOPTpCXCodszMjqB4IaXsOhgNlou9bKQlqhbCaEc4EL1xf91zbqd-ANeBz1OMB6WHEu5VahgdFOoYJk4Xg9Ikghl8TpKw2LhkYR-0hTElJzhBiGIuC_PwPch2m6MumVMsLpMMIF9CXPWipS_vlY0KpamZKdU4o70pVOW9g8R9UORY2zgQPgyv-g4SzfYKJIaUIw8uEGKlZfGqWl5rlpR7FVzI-_b2YF_yz2ugfChLTcQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>850419101</pqid></control><display><type>article</type><title>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</title><source>PubMed Central</source><creator>Al-Talib, Hassanain I ; Yean, Chan Y ; Al-Jashamy, Karim ; Hasan, Habsah</creator><creatorcontrib>Al-Talib, Hassanain I ; Yean, Chan Y ; Al-Jashamy, Karim ; Hasan, Habsah</creatorcontrib><description>Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility.
This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years.
The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P>.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin.
The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.</description><identifier>ISSN: 0256-4947</identifier><identifier>EISSN: 0975-4466</identifier><identifier>DOI: 10.4103/0256-4947.67077</identifier><identifier>PMID: 20697171</identifier><language>eng</language><publisher>Saudi Arabia: Medknow Publications and Media Pvt. Ltd</publisher><subject>Adult ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Cross Infection - drug therapy ; Cross Infection - epidemiology ; Cross Infection - prevention & control ; Diagnosis ; Disease Transmission, Infectious - statistics & numerical data ; Drug resistance in microorganisms ; Drug therapy ; Epidemiology ; Erythromycin - pharmacology ; Female ; Gentamicins - pharmacology ; Gram-positive bacteria ; Health aspects ; Hospitals ; Humans ; Incidence ; Infections ; Length of Stay ; Logistic Models ; Malaysia - epidemiology ; Methicillin-Resistant Staphylococcus aureus ; Microbial Sensitivity Tests ; Mortality ; Nosocomial infections ; Original ; Penicillin G - pharmacology ; Prevalence studies (Epidemiology) ; Regression analysis ; Risk Factors ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - prevention & control ; Staphylococcus aureus infections ; Staphylococcus infections ; Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology ; Vancomycin - pharmacology</subject><ispartof>Annals of Saudi medicine, 2010-09, Vol.30 (5), p.358-363</ispartof><rights>COPYRIGHT 2010 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt. Ltd. Sep 2010</rights><rights>Annals of Saudi Medicine 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</citedby><cites>FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941247/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941247/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20697171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Talib, Hassanain I</creatorcontrib><creatorcontrib>Yean, Chan Y</creatorcontrib><creatorcontrib>Al-Jashamy, Karim</creatorcontrib><creatorcontrib>Hasan, Habsah</creatorcontrib><title>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</title><title>Annals of Saudi medicine</title><addtitle>Ann Saudi Med</addtitle><description>Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility.
This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years.
The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P>.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin.
The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Cross Infection - drug therapy</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - prevention & control</subject><subject>Diagnosis</subject><subject>Disease Transmission, Infectious - statistics & numerical data</subject><subject>Drug resistance in microorganisms</subject><subject>Drug therapy</subject><subject>Epidemiology</subject><subject>Erythromycin - pharmacology</subject><subject>Female</subject><subject>Gentamicins - pharmacology</subject><subject>Gram-positive bacteria</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Length of Stay</subject><subject>Logistic Models</subject><subject>Malaysia - epidemiology</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Microbial Sensitivity Tests</subject><subject>Mortality</subject><subject>Nosocomial infections</subject><subject>Original</subject><subject>Penicillin G - pharmacology</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - prevention & control</subject><subject>Staphylococcus aureus infections</subject><subject>Staphylococcus infections</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology</subject><subject>Vancomycin - pharmacology</subject><issn>0256-4947</issn><issn>0975-4466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIlsKZG4rg0FO2_nZyQaoqSiu14lB6thx7sutV1l5sp9Je-O043bZiEbLksWbevPnwq6qPGC0YRvQMES4a1jG5EBJJ-ao6Rp3kDWNCvC7v5-hR9S6lNUIEMUrfVkcEiU5iiY-r37eQV864cXS-iZBcytrn-i7r7Wo3BhOMmVKtpwjF-JCKZ-P0WDs_gMku-DpH8DYVR30V0tblErz37gFictnVd9r5VN_qUe-S07WdovPLmpRWmnLJ99WbQY8JPjzZk-r-8tvPi6vm5sf364vzm8ZwjHNDh6HDjBHLewAOgvddSzEMFDi30pDOSiltZxllZTSpQUtOREtbgwaOCKEn1fWe1wa9VtvoNjruVNBOPTpCXCodszMjqB4IaXsOhgNlou9bKQlqhbCaEc4EL1xf91zbqd-ANeBz1OMB6WHEu5VahgdFOoYJk4Xg9Ikghl8TpKw2LhkYR-0hTElJzhBiGIuC_PwPch2m6MumVMsLpMMIF9CXPWipS_vlY0KpamZKdU4o70pVOW9g8R9UORY2zgQPgyv-g4SzfYKJIaUIw8uEGKlZfGqWl5rlpR7FVzI-_b2YF_yz2ugfChLTcQ</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Al-Talib, Hassanain I</creator><creator>Yean, Chan Y</creator><creator>Al-Jashamy, Karim</creator><creator>Hasan, Habsah</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE</general><general>Medknow Publications</general><general>King Faisal Specialist Hospital and Research Centre</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20100901</creationdate><title>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</title><author>Al-Talib, Hassanain I ; Yean, Chan Y ; Al-Jashamy, Karim ; Hasan, Habsah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Cross Infection - drug therapy</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - prevention & control</topic><topic>Diagnosis</topic><topic>Disease Transmission, Infectious - statistics & numerical data</topic><topic>Drug resistance in microorganisms</topic><topic>Drug therapy</topic><topic>Epidemiology</topic><topic>Erythromycin - pharmacology</topic><topic>Female</topic><topic>Gentamicins - pharmacology</topic><topic>Gram-positive bacteria</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Length of Stay</topic><topic>Logistic Models</topic><topic>Malaysia - epidemiology</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Microbial Sensitivity Tests</topic><topic>Mortality</topic><topic>Nosocomial infections</topic><topic>Original</topic><topic>Penicillin G - pharmacology</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - prevention & control</topic><topic>Staphylococcus aureus infections</topic><topic>Staphylococcus infections</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology</topic><topic>Vancomycin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Talib, Hassanain I</creatorcontrib><creatorcontrib>Yean, Chan Y</creatorcontrib><creatorcontrib>Al-Jashamy, Karim</creatorcontrib><creatorcontrib>Hasan, Habsah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep (ProQuest)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of Saudi medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Talib, Hassanain I</au><au>Yean, Chan Y</au><au>Al-Jashamy, Karim</au><au>Hasan, Habsah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</atitle><jtitle>Annals of Saudi medicine</jtitle><addtitle>Ann Saudi Med</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>30</volume><issue>5</issue><spage>358</spage><epage>363</epage><pages>358-363</pages><issn>0256-4947</issn><eissn>0975-4466</eissn><abstract>Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility.
This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years.
The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P>.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin.
The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.</abstract><cop>Saudi Arabia</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>20697171</pmid><doi>10.4103/0256-4947.67077</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0256-4947 |
ispartof | Annals of Saudi medicine, 2010-09, Vol.30 (5), p.358-363 |
issn | 0256-4947 0975-4466 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_be228b5ec5e346bb87720866da425465 |
source | PubMed Central |
subjects | Adult Anti-Bacterial Agents - pharmacology Antibiotics Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - prevention & control Diagnosis Disease Transmission, Infectious - statistics & numerical data Drug resistance in microorganisms Drug therapy Epidemiology Erythromycin - pharmacology Female Gentamicins - pharmacology Gram-positive bacteria Health aspects Hospitals Humans Incidence Infections Length of Stay Logistic Models Malaysia - epidemiology Methicillin-Resistant Staphylococcus aureus Microbial Sensitivity Tests Mortality Nosocomial infections Original Penicillin G - pharmacology Prevalence studies (Epidemiology) Regression analysis Risk Factors Staphylococcal Infections - drug therapy Staphylococcal Infections - epidemiology Staphylococcal Infections - prevention & control Staphylococcus aureus infections Staphylococcus infections Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology Vancomycin - pharmacology |
title | Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methicillin-resistant%20Staphylococcus%20aureus%20nosocomial%20infection%20trends%20in%20Hospital%20Universiti%20Sains%20Malaysia%20during%202002-2007&rft.jtitle=Annals%20of%20Saudi%20medicine&rft.au=Al-Talib,%20Hassanain%20I&rft.date=2010-09-01&rft.volume=30&rft.issue=5&rft.spage=358&rft.epage=363&rft.pages=358-363&rft.issn=0256-4947&rft.eissn=0975-4466&rft_id=info:doi/10.4103/0256-4947.67077&rft_dat=%3Cgale_doaj_%3EA235994172%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=850419101&rft_id=info:pmid/20697171&rft_galeid=A235994172&rfr_iscdi=true |